Search clinical trials for: BR900A

Total 23 results

Boryung Pharmaceutical Co., Ltd

Completed

To Evaluate the Pharmacokinetics and Safety of Oral Administration of BR9001 Compared With BR900A in Healthy Subjects

Rheumatoid Arthritis

Korea, Republic of
Boryung Pharmaceutical Co., Ltd

Completed

A Study to Compare the Pharmacokinetics of BR9003A and BR9003 in Healthy Adult Subjects

Smoking Cessation

Korea, Republic of
Boryung Pharmaceutical Co., Ltd

Completed

A Multi Doses Study to Compare the Pharmacokinetics of BR9003A and BR9003 in Healthy Adult Subjects

Smoking Cessation

Korea, Republic of
Boryung Pharmaceutical Co., Ltd

Completed

A Study to Evaluate the Pharmacokinetics and Safety Between Single Administration of "BR6002" and Coadministration of "BR6002A" and "BR6002B" Under Fasting Conditions in Healthy Adult Volunteers

Gastric or Duodenal Ulcers

Korea, Republic of
Boryung Pharmaceutical Co., Ltd

Completed

A Study to Evaluate the Pharmacokinetics and Safety Between Single Administration of "BR6002" and Coadministration of "BR6002A" and "BR6002B" Under Fed Conditions in Healthy Adult Volunteers

Gastric or Duodenal Ulcer

Korea, Republic of
Boryung Pharmaceutical Co., Ltd

Recruiting

A Study to Compare the Pharmacokinetics and the Safety Between a Fixed-dose Combination Administration of "BR3005" and Co-administration of "BR3005-1" and "BR3005-2" Under Fasting Conditions in Healthy Adult Volunteers

Type 2 Diabetes Mellitus

Korea, Republic of
Boryung Pharmaceutical Co., Ltd

Recruiting

A Study to Compare the Pharmacokinetics and the Safety Between a Fixed-dose Combination Administration of "BR3005" and Co-administration of "BR3005-1" and "BR3005-2" Under Fed Conditions in Healthy Adult Volunteers

Type2 Diabetes Mellitus

Korea, Republic of
Boryung Pharmaceutical Co., Ltd

Completed

A Study to Evaluate Drug-drug Interactions and Safety Between "BR3006-1", "BR3006-2", and "BR3006-3" in Healthy Volunteers

Diabetes Mellitus

Korea, Republic of
Boryung Pharmaceutical Co., Ltd

Completed

A Study to Compare the Pharmacokinetics of BR4002 and BR4002-1 in Healthy Volunteers

Dementia Alzheimers

Korea, Republic of
Boryung Pharmaceutical Co., Ltd

Completed

A Study to Evaluate the Drug-drug Interaction and Safety Between "BR6001-1" and "BR6001-2"

Gastric or Duodenal Ulcer

Korea, Republic of
Boryung Pharmaceutical Co., Ltd

Completed

A Clinical Trial to Compare the Pharmacokinetics and Bioequivalence of "BR2008" With "BR2008-1" in Healthy Volunteers

Hepatocellular Carcinoma

Korea, Republic of
Seoul St. Mary's Hospital

Unknown

Heart Rate Variability (HRV) in Pituitary Adenoma

Pituitary Adenoma

Korea, Republic of
Beijing Boren Hospital

Terminated

A Study of OVV-01 Injection in Combination With IBR900 Cell Injection in Patients With Advanced Malignant Tumors

Advanced Solid Tumor | Relapsed/Refractory Lymphoma

China
Boryung Pharmaceutical Co., Ltd

Completed

A Study to Compare the Pharmacokinetics and Safety Between BR9004 and BR9004-1 in Healthy Male Volunteers

Prostate Cancer

Korea, Republic of
Boryung Pharmaceutical Co., Ltd

Completed

A Study to Evaluate Drug-drug Interactions Between BR9006-1 and BR9006-2 in Healthy Male Volunteers.

Overactive Bladder | Benign Prostatic Hyperplasia (BPH)

Korea, Republic of
Shandong Public Health Clinical Center
Imbioray (Hangzhou) Biomedicine Co., Ltd.

Not yet recruiting

IBR900 Cell Injection Combined With Lenvatinib or Bevacizumab in the Treatment of Advanced Primary Liver Cancer

Advanced Primary Liver Cancer
Boryung Pharmaceutical Co., Ltd

Completed

A Study to Evaluate the Efficacy and Safety of Pioglitazone 15mg or 30mg Add-on in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin and Dapagliflozin

Type2 Diabetes

Korea, Republic of
University of Washington
Janssen Research & Development, LLC

Terminated

Erdafitinib and Abiraterone Acetate or Enzalutamide in Treating Patients With Double Negative Prostate Cancer

Castration-Resistant Prostate Carcinoma | Metastatic Prostate Carcinoma | Prostate Adenocarcinoma | Stage IV Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8 | Double-Negative Prostate Carcinoma

United States
Stanford University

Not yet recruiting

Panitumumab-IRDye800 to Detect Pediatric Neoplasms During Neurosurgical Procedures

Brain Tumor

United States
Boryung Pharmaceutical Co., Ltd

Completed

A Study to Evaluate the Pharmacokinetics After Administration of BR3003 and Co-administration of BR3003B and BR3003C.

Diabetes Mellitus, Type 2

Korea, Republic of
Andrei Iagaru
National Cancer Institute (NCI); National Institutes of Health (NIH)

Completed

Panitumumab-IRDye800 and 89Zr-Panitumumab in Identifying Metastatic Lymph Nodes in Patients With Squamous Cell Head and Neck Cancer

Squamous Cell Carcinoma of the Head and Neck | Carcinoma of the Head and Neck

United States
Eben Rosenthal
National Institutes of Health (NIH)

Active, not recruiting

Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery

Malignant Glioma | Malignant Brain Neoplasm

United States
Mayo Clinic

Recruiting

Risk Stratified De-escalated Hormone Therapy With Radiation Therapy for the Treatment Prostate Cancer

Prostate Adenocarcinoma | Oligometastatic Prostate Carcinoma

United States

3

Subscribe